TORONTO--(BUSINESS WIRE)--Today, Medworxx Solutions Inc. ("Medworxx") (TSX VENTURE: MWX) announced the company has licensed its Patient Flow Platform to Crouse Hospital (“Crouse”), an acute care provider with more than 500 beds, serving Central and Northern New York. Crouse has licensed the Medworxx Clinical Criteria module to deliver necessary improvements in patient throughput to continue their delivery of high quality care. The decision to invest in the Clinical Criteria module followed the delivery of the Medworxx Patient Throughput Review.
Medworxx will interface with the existing Siemens Soarian EHR to support clinical workflow. The Clinical Criteria module is designed to provide advanced patient flow analytics in real-time. The derived analytics can be shared across the organization to provide Crouse care coordinators, case managers and multi-disciplinary team with a system to organize and prioritize patient flow across the hospital. The Medworxx Clinical Criteria module will enable the hospital to identify, in real-time, the clinical appropriateness of each patient’s level of care (and whether it’s appropriate to their clinical needs), each day, and will provide clinicians with the ability to match patients with the right level of care, at the right time and in the most appropriate setting.
“Crouse Hospital recognized a need to understand our barriers to optimal patient throughput and make that information transparent to the entire organization on a real-time basis. Prior to selecting Medworxx, the information associated with our Utilization Management process and bed placement procedures was not easily accessible by the organization as a whole. Medworxx will allow us to understand and act on patient flow barriers as they occur to enhance the timeliness of discharge and create viable solutions to eliminate identifiable causes of avoidable delays in hospital services,” said Barbara Drapola, Director of Care Coordination Services.
“It is gratifying to us that Crouse has invested in our patient flow platform to support their case management and care coordination programs in order to improve patient throughput and flow. We know that managing patient flow more effectively will lead to the continued high quality of care and access to care that Crouse is committed to. The partnership with Crouse is further evidence of the opportunity for Medworxx in the US as our customer base there begins to grow,” said Niels Tofting, SVP, Business Development, Medworxx.
Medworxx delivers health information technology solutions to over 400 hospitals internationally, including Canada, United States, United Kingdom, France and Australia. Medworxx helps hospitals meet patient flow challenges and requirements for compliance and education. Medworxx Clinical Criteria —the flagship component of Medworxx Patient Flow, which also includes electronic bed management and independent assessment components—is currently used to manage 32% of the acute-care beds in Canada as well as acute-care beds in a rapidly increasing number of Trusts and CCGs in the UK. Founded in 2004, Medworxx Inc. is based in Toronto, Canada, and publicly traded on the TSX Venture Exchange: MWX. Visit: www.medworxx.com
The statements made in this press release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from the company’s expectations and projections. The TSX Venture Exchange has not reviewed this press release and neither approved nor disapproved the information contained in this press release.